Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz

Affiliations

Comment

Marc I Chimowitz et al. Stroke. 2012 Oct.

. 2012 Oct;43(10):2806-9.

doi: 10.1161/strokeaha.112.661041.

¹ Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA. mchimow@musc.edu

No abstract available

Comment on

Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz et al in the new England Journal of Medicine.
Abou-Chebl A, Steinmetz H. Abou-Chebl A, et al. Stroke. 2012 Feb;43(2):616-20. doi: 10.1161/STROKEAHA.111.641563. Epub 2012 Jan 12. Stroke. 2012. PMID: 22246688

1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003. - PMC - PubMed
1. Leung TW, Yu SC, Wong KS. Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial. Int J Stroke. 2011;6:312–4. - PubMed
1. Qureshi AI, Al-Senani FM, Husain S, Janjua NA, Lanzino G, Lavados PM, et al. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations. J Neuroimaging. 2012;22:1–13. - PubMed
1. Wong GK, Poon WS. Time to reflect on surgery and neuro-intervention for intracranial atherosclerotic diseases. J Clin Neurosci. 2012;19:222–3. - PubMed
1. Henkes H, Bäzner H, Nelson PK. Comment on: Stenting versus aggressive medical therapy for intracranial arterial stenosis : Chimowitz MI, Lynn MJ, Derdeyn CP, et al. N Engl J Med. 2011;365:993–1003. Clin Neuroradiol. 2011;21:257–9. - PubMed